Wafaa Mamilli

Chief Digital and Technology Officer (Member of the enlarged CEC since 2025)
Zur deutschen Version

Personal Data

Nationality
France, Morocco, US

Year of Birth
1967

Education

1984–1988
INSEA Rabat – Morocco, Master’s degree in Computer Science 

1988–1989
Université de Rennes, France – Master’s degree in Business Applications of Technology 

2007–2007
London Business School, ADP General Management 

2015–2015
Harvard Business School, Advanced Management Program

2022–2022
Stanford University Graduate School of Business, Public Board leadership

Professional experience

1995–2005
Lilly France, Varied technology and program management roles

2005–2008
Lilly, Director EMEA governance and portfolio management, UK

2008–2009 
Lilly, Director Global Manufacturing and Quality Center of Excellence, US

2009–2011
Lilly, Director Global Organisational Change Management

2011–2013
Lilly, Senior Director Real World Evidence and Global Shared Services

2013–2014
Lily, Senior Director Real World Evidence and Next Generation Development of Drugs

2014–2016
Lilly, Chief Information Office, Diabetes and Real World Evidence

2016–2019
Lilly, Vice President Global Chief Information Security Officer

2019–2020
Lilly, Global Chief Information Officer Business units

2020–2022
Zoetis, EVP – Global Chief Information and Digital Officer

2022–2025
Zoetis, EVP – Chief Digital and Technology Officer & Group President China, Brazil and Precision Animal Health

Since 2025
Roche, Chief Digital Technology Officer

Present external mandates

Since 2021
FISERV, inc., Member of the Board of Directors

Other activities / non-profit activities / memberships

2016–2019
Center for Interfaith Cooperation – Indiana – Board member

2018–2019
Healthcare – ISAC Board member

Since 2021
T200 – Elevating women in Tech – Board member (non for profit)

Awards / Honors

2022
MIT Sloan Innovation Leadership Award

2022
Forbes – CIO Next for Innovation and Leadership

Möchten Sie den Inhalt auf Deutsch lesen?

Discover more

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubePharma solutionsMedia libraryAnnual Report 2024Report a potential side effectPrivacy noticeLegal statementAccessibility statement